Garda Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History

Garda Capital Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-11,100	Closed	-$6.87M	–	492
2024 Q3	$6.87M	Buy	11,100 +9,400	+553%	+$5.56M	0.19%	154
2024 Q2	$940K	Buy	+1,700	New	+$974K	0.03%	347
2023 Q4	–	Sell	-6,600	Closed	-$3.34M	–	684
2023 Q3	$3.34M	Sell	6,600 -5,000	-43%	-$2.66M	0.15%	132
2023 Q2	$6.05M	Sell	11,600 -1,500	-11%	-$809K	0.34%	66
2023 Q1	$7.55M	Buy	13,100 +100	+0.8%	+$56.4K	0.37%	62
2022 Q4	$7.16M	Buy	+13,000	New	+$6.89M	0.4%	61

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Garda Capital Partners's TMO Position: Q4 2023 in Review

Garda Capital Partners sold out of Thermo Fisher Scientific (TMO) in Q4 2023, closing a stake of 2,125 shares — an estimated $1.08M sold.

Garda Capital Partners first reported a position in TMO in Q2 2023 and held it in 2 quarters. The position peaked at $1.08M in Q3 2023. 2,488 funds tracked by Wall St. Rank hold TMO as of Q4 2023.

Garda Capital Partners reported no remaining Thermo Fisher Scientific position as of Q4 2023 after selling out during the quarter.
Garda Capital Partners sold 2,125 Thermo Fisher Scientific shares in Q4 2023, an estimated $1.08M.
Garda Capital Partners first reported a position in Thermo Fisher Scientific in Q2 2023 and held it in 2 quarters.
Garda Capital Partners's Thermo Fisher Scientific position peaked at $1.08M in Q3 2023.
2,488 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2023.

Based on Garda Capital Partners's 13F filing for Q4 2023, filed 12 Feb 2024.